SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "(LAR1:gu) pers:(Blennow Kaj 1958) mspu:(chapter) srt2:(2010-2014)"

Search: (LAR1:gu) pers:(Blennow Kaj 1958) mspu:(chapter) > (2010-2014)

  • Result 1-5 of 5
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Blennow, Kaj, 1958, et al. (author)
  • Fluid Biomarkers in Alzheimer Disease, 91
  • 2012
  • In: The biology of Alzheimer disease / edited by Dennis J. Selkoe, David M. Holtzman, and Eckhard Mandelkow.. - Cold Spring Harbor, N.Y. : Cold Spring Harbor Laboratory Press. - 9781936113446 ; , s. 91-114
  • Book chapter (peer-reviewed)
  •  
2.
  • Blennow, Kaj, 1958, et al. (author)
  • Likvoranalyser : Del av: Sjukdomar i centrala nervsystemet
  • 2012
  • In: Laurells Klinisk kemi i praktisk medicin 9., [rev. och utök.] uppl. /redaktion: Peter Nilsson-Ehle, Maria Berggren Söderlund, Elvar Theodorsson ; redaktionskommitté: Charlotte Becker, Kjell Grankvist, Anders Grubb, Göran Lindstedt, Per Simonsson. - LUND : Studentlitteratur. - 9789144047874
  • Book chapter (other academic/artistic)
  •  
3.
  • Zetterberg, Henrik, 1973, et al. (author)
  • Biokemiska utredningar vid kognitiv sjukkdom
  • 2012
  • In: Kognitiv medicin / Lars-Olof Wahlund, Christer Nilsson, Anders Wallin (red.). - Stockholm : Norstedts förlag. - 9789113023229 ; , s. 134-140
  • Book chapter (other academic/artistic)
  •  
4.
  • Zetterberg, Henrik, 1973, et al. (author)
  • CSF in Alzheimer's Disease
  • 2014
  • In: Advances in Clinical Chemistry. Volume 65. Gregory S. Makowski (Ed.). - : Academic Press Inc.. - 9780128022665 ; , s. 143-172
  • Book chapter (other academic/artistic)abstract
    • Alzheimer's disease (AD) is a progressive brain amyloidosis that injures brain regions involved in memory consolidation and other cognitive functions. Neuropathologically, the disease is characterized by accumulation of a 42-amino acid protein called amyloid β, and N-terminally truncated fragments thereof, in extracellular senile plaques together with intraneuronal inclusions of hyperphosphorylated tau protein in neurofibrillary tangles, and neuronal and axonal degeneration and loss. Clinical chemistry tests for these pathologies have been developed for use on cerebrospinal fluid samples. Here, we review what these markers have taught us on the disease process in AD and how they can be implemented in routine clinical chemistry. We also provide an update on new marker development and ongoing analytical standardization effort. © 2014 Elsevier Inc.
  •  
5.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-5 of 5

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view